SEMA6C and familial pancreatic carcinoma: To validate these findings, we ectopically expressed SEMA6C in MIA PaCa-2 pancreatic cancer cells that had very low levels of endogenous SEMA6C expression and compared the expression profiles by using next-generation sequencing to identify the altered pathways.